Provided by Tiger Trade Technology Pte. Ltd.

Arcus Biosciences Inc.

25.28
+0.63002.56%
Volume:98.76K
Turnover:2.49M
Market Cap:3.22B
PE:-6.54
High:25.57
Open:25.29
Low:25.05
Close:24.65
52wk High:31.74
52wk Low:11.68
Shares:127.33M
Float Shares:89.84M
Volume Ratio:0.66
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8641
EPS(LYR):-3.2900
ROE:-90.82%
ROA:-30.39%
PB:6.94
PE(LYR):-7.68

Loading ...

Arcus Biosciences Initiated at Buy by TD Cowen

Dow Jones
·
Yesterday

U.S. Stocks on the MOVE-Intel, Axon Enterprise, J.B. Hunt

Reuters
·
Yesterday

Arcus Gains After TD Cowen Starts Coverage with 'buy' Rating

Reuters
·
Yesterday

TD Cowen Initiates Arcus Biosciences at Buy

MT Newswires Live
·
Yesterday

Arcus Biosciences initiated with a Buy at TD Cowen

TIPRANKS
·
Yesterday

U.S. Research Roundup-Domino's, McDonald's, Starbucks

Reuters
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cooper Co (COO) and Arcus Biosciences (RCUS)

TIPRANKS
·
Sep 10

Arcus Biosciences Grants New Hire Options for 26,350 Shares, RSUs for 13,200 Shares

Reuters
·
Sep 10

Arcus Biosciences Price Target Raised to $40.00/Share from $35.00 by Truist Securities

Dow Jones
·
Sep 09

Arcus Biosciences, Inc. : Truist Securities Raises Target Price to $40 from $35

THOMSON REUTERS
·
Sep 08

Arcus Biosciences to Present at Citi 2026 Biotech Back to School Conference

Reuters
·
Aug 27

Arcus Biosciences Chief Accounting Officer Alexander Azoy Sells 2,827 Shares for $84,810

Reuters
·
Aug 25

What Arcus Biosciences (RCUS)'s Steep Revenue Drop and 2026 Guidance Cut Means For Shareholders

Simply Wall St.
·
Aug 16

Arcus Biosciences Memberi Hibah Induksi: Opsi 2.850 Saham Dan 1.450 RSU Untuk Karyawan Baru

Reuters
·
Aug 12

Arcus Biosciences' Casdatifan Therapy Could be Launched in 2028, Morgan Stanley Says

MT Newswires Live
·
Aug 11

Morgan Stanley Adjusts Price Target on Arcus Biosciences to $23 From $22, Maintains Equalweight Rating

MT Newswires Live
·
Aug 10

SIGA Technologies Q2 Revenue, Profit Drop as Contract Ends

Reuters
·
Aug 07

Arcus Biosciences Price Target Raised to $43.00/Share from $41.00 by Wedbush

Dow Jones
·
Aug 06

Wedbush Adjusts Price Target on Arcus Biosciences to $43 From $41, Maintains Outperform Rating

MT Newswires Live
·
Aug 06

Lexicon Pharmaceuticals Posts Q2 Net Loss

Reuters
·
Aug 06